EUVIMEDΑνακαλύψτε το EUVIMED
Open access · CC BY 4.0

Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness

Alexandra Bühler iD, Richard J Cook iD, Jerald F Lawless iD

Statistics in Medicine · 2024-12-20 · 43 (29) · 5513-5533

DOI: 10.1002/sim.10236 ↗

At a glance

Journal article in Statistics in Medicine, published online on 2024-10-29. Written by Alexandra Bühler and 2 co-authors. Institution: Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Major MEDLINE topics: Breast Neoplasms, Models, Statistical. Cited 3 times so far (Crossref); 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Regression analyses based on transformations of cumulative incidence functions are often adopted when modeling and testing for treatment effects in clinical trial settings involving competing and semi‐competing risks. Common frameworks include the Fine–Gray model and models based on direct binomial regression. Using large sample theory we derive the limiting values of treatment effect estimators based on such models when the data are generated according to multiplicative intensity‐based models, and show that the estimand is sensitive to several process features. The rejection rates of hypothesis tests based on cumulative incidence function regression models are also examined for null hypotheses of different types, based on which a robustness property is established. In such settings supportive secondary analyses of treatment effects are essential to ensure a full understanding of the nature of treatment effects. An application to a palliative study of individuals with breast cancer metastatic to bone is provided for illustration.

Subjects

MeSH terms (MEDLINE)

Breast NeoplasmsModels, StatisticalHumansRegression AnalysisFemaleClinical Trials as TopicBone NeoplasmsData Interpretation, StatisticalIncidence

Author keywords

clinical trialscompeting risksestimandsgeneralized linear modelslarge sample resultsrobustnesstesting

Authors and institutions

  • Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.

ORCID profiles: Alexandra Bühler, Richard J Cook, Jerald F Lawless

Funding

  • Natural Sciences and Engineering Research Council of Canada

Cite

APA

Bühler, A., Cook, R. J., & Lawless, J. F. (2024). Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness. Statistics in Medicine, 43(29), 5513-5533. https://doi.org/10.1002/sim.10236

Vancouver

Bühler A, Cook RJ, Lawless JF. Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness. Statistics in Medicine. 2024;43(29):5513-5533. doi:10.1002/sim.10236

BibTeX
@article{Bhler2024,
  author = {Bühler, Alexandra and Cook, Richard J and Lawless, Jerald F},
  title = {Estimands and Cumulative Incidence Function Regression in Clinical Trials: Some New Results on Interpretability and Robustness},
  journal = {Statistics in Medicine},
  year = {2024},
  volume = {43},
  number = {29},
  pages = {5513--5533},
  doi = {10.1002/sim.10236}
}
Start for free →